Stocks
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -35 949% | -1 308% | |||||
| Changes by years, y/y, % | ||||||||
Iovance Biotherapeutics. EBITDA margin, %
Iovance Biotherapeutics. EBITDA margin, changes, pp
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | -46 255% | -25 237% | -23 141% | -15 079% | -292.7% | -1 308% | |
| Changes by years, y/y, % | +45 962pp | |||||||
| Changes by quarters, q/q, % | +21 018pp | +2 095pp | +8 062pp | +14 786pp | ||||
